Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Irish Journal of Medical Science|February 18, 2009
The effects of diet and orlistat on body weight and lipid profiles in high risk Chinese patients with coronary artery disease, obesity and hypercholesterolemiaK W Chan, W S Leung, Y S Fung, et al.
Diabetes & Metabolism|March 6, 2010
Hypoadiponectinaemia enhances waist circumference as a predictor of glucose intolerance and clustering of risk factors in Chinese menG T C Ko, W Y So, P Tong, et al.
Acta Diabetologica|July 16, 2003
Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetesG T C Ko, J C N Chan, C C Chow, et al.
Clinical Pharmacology and Therapeutics|February 5, 2010
ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatinB Tomlinson, M Hu, V W Y Lee, et al.
International Journal of Obesity (2005)|May 24, 2006
Association between sleeping hours, working hours and obesity in Hong Kong Chinese: the 'better health for better Hong Kong' health promotion campaignG T C Ko, J C N Chan, A W Y Chan, et al.
Scandinavian Journal of Rheumatology|February 6, 2010
Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosusC C Mok, W L Poon, J P S Lai, et al.
Diabetes, Obesity & Metabolism|April 16, 2011
A randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose-lipid control in type 2 diabetesA P S Kong, A Yamasaki, R Ozaki, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|August 8, 2002
Obesity and cardiovascular risk factors in Hong Kong ChineseZ S K Lee, J A J H Critchley, G T C Ko, et al.
Diabetes, Obesity & Metabolism|April 26, 2006
The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiencyP C Y Tong, G T C Ko, W-B Chan, et al.
Diabetes, Obesity & Metabolism|December 22, 2005
Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndromeG T-C Ko, W-Y So, N N Chan, et al.
Pageof 3